Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element

Koji Matsuo, Yutaka Takazawa, Malcolm S. Ross, Esther Elishaev, Mayu Yunokawa, Todd B. Sheridan, Stephen H. Bush, Merieme M. Klobocista, Erin A. Blake, Tadao Takano, Tsukasa Baba, Shinya Satoh, Masako Shida, Yuji Ikeda, Sosuke Adachi, Takuhei Yokoyama, Munetaka Takekuma, Shiori Yanai, Satoshi Takeuchi, Masato Nishimura & 29 others Keita Iwasaki, Marian S. Johnson, Masayuki Yoshida, Ardeshir Hakam, Hiroko Machida, Paulette Mhawech-Fauceglia, Yutaka Ueda, Kiyoshi Yoshino, Hiroshi Kajiwara, Kosei Hasegawa, Masanori Yasuda, Takahito M. Miyake, Takuya Moriya, Yoshiaki Yuba, Terry Morgan, Tomoyuki Fukagawa, Tanja Pejovic, Tadayoshi Nagano, Takeshi Sasaki, Abby M. Richmond, Miriam D. Post, Mian M.K. Shahzad, Dwight D. Im, Hiroshi Yoshida, Kohei Omatsu, Frederick R. Ueland, Joseph L. Kelley, Rouzan G. Karabakhtsian, Lynda D. Roman

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: To examine significance of sarcoma dominance (SD) patterns in uterine carcinosarcoma (UCS). Methods: This is a secondary analysis of multicenter retrospective study examining women with stages I-IV UCS who underwent primary surgery. SD was defined as >50% of sarcoma component in uterine tumor. SD patterns were grouped as homologous sarcoma without SD (homo/non-dominance, n = 351), heterologous sarcoma without SD (hetero/non-dominance, n = 174), homologous sarcoma with SD (homo/dominance, n = 175), and heterologous sarcoma with SD (hetero/dominance, n = 189), and correlated to tumor characteristics and survival. Results: SD patterns were significantly associated with age, body habitus, carcinoma type, tumor size, depth of myometrial invasion, and nodal metastasis (all, P < 0.05). On univariate analysis, SD was associated with decreased progression-free survival (PFS) and cause-specific survival (CSS) in homologous cases (both, P < 0.05) but not in heterologous cases. On multivariate models, both homologous and heterologous SD patterns remained independent prognostic factors for decreased PFS (adjusted-hazard ratio [HR] ranges: homo/dominance 1.35–1.69, and hetero/dominance 1.47–1.64) and CSS (adjusted-HR ranges: 1.52–1.84 and 1.66–1.81, respectively) compared to homo/non-dominance (all, P < 0.05). Among stage I-III disease, when tumors had SD, adding radiotherapy to chemotherapy was significantly associated with improved PFS (adjusted-HR: homo/dominance 0.49, and hetero/dominance 0.45) and CSS (0.36 and 0.31, respectively) compared to chemotherapy alone (all, P < 0.05); contrary, this association was not observed with absence of SD (all, P > 0.05). Conclusion: In UCS, SD impacts survival in homologous but not in heterologous type. Regardless of sarcoma types, SD was associated with decreased survival in UCS; adding radiotherapy to chemotherapy may be an effective postoperative strategy.

Original languageEnglish (US)
Pages (from-to)433-440
Number of pages8
JournalSurgical Oncology
Volume27
Issue number3
DOIs
StatePublished - Sep 1 2018

Fingerprint

Carcinosarcoma
Sarcoma
Survival
Neoplasms

Keywords

  • Heterologous
  • Homologous
  • Sarcoma dominance
  • Survival
  • Uterine carcinosarcoma

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Matsuo, K., Takazawa, Y., Ross, M. S., Elishaev, E., Yunokawa, M., Sheridan, T. B., ... Roman, L. D. (2018). Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element. Surgical Oncology, 27(3), 433-440. https://doi.org/10.1016/j.suronc.2018.05.017

Characterizing sarcoma dominance pattern in uterine carcinosarcoma : Homologous versus heterologous element. / Matsuo, Koji; Takazawa, Yutaka; Ross, Malcolm S.; Elishaev, Esther; Yunokawa, Mayu; Sheridan, Todd B.; Bush, Stephen H.; Klobocista, Merieme M.; Blake, Erin A.; Takano, Tadao; Baba, Tsukasa; Satoh, Shinya; Shida, Masako; Ikeda, Yuji; Adachi, Sosuke; Yokoyama, Takuhei; Takekuma, Munetaka; Yanai, Shiori; Takeuchi, Satoshi; Nishimura, Masato; Iwasaki, Keita; Johnson, Marian S.; Yoshida, Masayuki; Hakam, Ardeshir; Machida, Hiroko; Mhawech-Fauceglia, Paulette; Ueda, Yutaka; Yoshino, Kiyoshi; Kajiwara, Hiroshi; Hasegawa, Kosei; Yasuda, Masanori; Miyake, Takahito M.; Moriya, Takuya; Yuba, Yoshiaki; Morgan, Terry; Fukagawa, Tomoyuki; Pejovic, Tanja; Nagano, Tadayoshi; Sasaki, Takeshi; Richmond, Abby M.; Post, Miriam D.; Shahzad, Mian M.K.; Im, Dwight D.; Yoshida, Hiroshi; Omatsu, Kohei; Ueland, Frederick R.; Kelley, Joseph L.; Karabakhtsian, Rouzan G.; Roman, Lynda D.

In: Surgical Oncology, Vol. 27, No. 3, 01.09.2018, p. 433-440.

Research output: Contribution to journalArticle

Matsuo, K, Takazawa, Y, Ross, MS, Elishaev, E, Yunokawa, M, Sheridan, TB, Bush, SH, Klobocista, MM, Blake, EA, Takano, T, Baba, T, Satoh, S, Shida, M, Ikeda, Y, Adachi, S, Yokoyama, T, Takekuma, M, Yanai, S, Takeuchi, S, Nishimura, M, Iwasaki, K, Johnson, MS, Yoshida, M, Hakam, A, Machida, H, Mhawech-Fauceglia, P, Ueda, Y, Yoshino, K, Kajiwara, H, Hasegawa, K, Yasuda, M, Miyake, TM, Moriya, T, Yuba, Y, Morgan, T, Fukagawa, T, Pejovic, T, Nagano, T, Sasaki, T, Richmond, AM, Post, MD, Shahzad, MMK, Im, DD, Yoshida, H, Omatsu, K, Ueland, FR, Kelley, JL, Karabakhtsian, RG & Roman, LD 2018, 'Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element' Surgical Oncology, vol. 27, no. 3, pp. 433-440. https://doi.org/10.1016/j.suronc.2018.05.017
Matsuo, Koji ; Takazawa, Yutaka ; Ross, Malcolm S. ; Elishaev, Esther ; Yunokawa, Mayu ; Sheridan, Todd B. ; Bush, Stephen H. ; Klobocista, Merieme M. ; Blake, Erin A. ; Takano, Tadao ; Baba, Tsukasa ; Satoh, Shinya ; Shida, Masako ; Ikeda, Yuji ; Adachi, Sosuke ; Yokoyama, Takuhei ; Takekuma, Munetaka ; Yanai, Shiori ; Takeuchi, Satoshi ; Nishimura, Masato ; Iwasaki, Keita ; Johnson, Marian S. ; Yoshida, Masayuki ; Hakam, Ardeshir ; Machida, Hiroko ; Mhawech-Fauceglia, Paulette ; Ueda, Yutaka ; Yoshino, Kiyoshi ; Kajiwara, Hiroshi ; Hasegawa, Kosei ; Yasuda, Masanori ; Miyake, Takahito M. ; Moriya, Takuya ; Yuba, Yoshiaki ; Morgan, Terry ; Fukagawa, Tomoyuki ; Pejovic, Tanja ; Nagano, Tadayoshi ; Sasaki, Takeshi ; Richmond, Abby M. ; Post, Miriam D. ; Shahzad, Mian M.K. ; Im, Dwight D. ; Yoshida, Hiroshi ; Omatsu, Kohei ; Ueland, Frederick R. ; Kelley, Joseph L. ; Karabakhtsian, Rouzan G. ; Roman, Lynda D. / Characterizing sarcoma dominance pattern in uterine carcinosarcoma : Homologous versus heterologous element. In: Surgical Oncology. 2018 ; Vol. 27, No. 3. pp. 433-440.
@article{67188b9e611a45349dd70e45e9586269,
title = "Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element",
abstract = "Objective: To examine significance of sarcoma dominance (SD) patterns in uterine carcinosarcoma (UCS). Methods: This is a secondary analysis of multicenter retrospective study examining women with stages I-IV UCS who underwent primary surgery. SD was defined as >50{\%} of sarcoma component in uterine tumor. SD patterns were grouped as homologous sarcoma without SD (homo/non-dominance, n = 351), heterologous sarcoma without SD (hetero/non-dominance, n = 174), homologous sarcoma with SD (homo/dominance, n = 175), and heterologous sarcoma with SD (hetero/dominance, n = 189), and correlated to tumor characteristics and survival. Results: SD patterns were significantly associated with age, body habitus, carcinoma type, tumor size, depth of myometrial invasion, and nodal metastasis (all, P < 0.05). On univariate analysis, SD was associated with decreased progression-free survival (PFS) and cause-specific survival (CSS) in homologous cases (both, P < 0.05) but not in heterologous cases. On multivariate models, both homologous and heterologous SD patterns remained independent prognostic factors for decreased PFS (adjusted-hazard ratio [HR] ranges: homo/dominance 1.35–1.69, and hetero/dominance 1.47–1.64) and CSS (adjusted-HR ranges: 1.52–1.84 and 1.66–1.81, respectively) compared to homo/non-dominance (all, P < 0.05). Among stage I-III disease, when tumors had SD, adding radiotherapy to chemotherapy was significantly associated with improved PFS (adjusted-HR: homo/dominance 0.49, and hetero/dominance 0.45) and CSS (0.36 and 0.31, respectively) compared to chemotherapy alone (all, P < 0.05); contrary, this association was not observed with absence of SD (all, P > 0.05). Conclusion: In UCS, SD impacts survival in homologous but not in heterologous type. Regardless of sarcoma types, SD was associated with decreased survival in UCS; adding radiotherapy to chemotherapy may be an effective postoperative strategy.",
keywords = "Heterologous, Homologous, Sarcoma dominance, Survival, Uterine carcinosarcoma",
author = "Koji Matsuo and Yutaka Takazawa and Ross, {Malcolm S.} and Esther Elishaev and Mayu Yunokawa and Sheridan, {Todd B.} and Bush, {Stephen H.} and Klobocista, {Merieme M.} and Blake, {Erin A.} and Tadao Takano and Tsukasa Baba and Shinya Satoh and Masako Shida and Yuji Ikeda and Sosuke Adachi and Takuhei Yokoyama and Munetaka Takekuma and Shiori Yanai and Satoshi Takeuchi and Masato Nishimura and Keita Iwasaki and Johnson, {Marian S.} and Masayuki Yoshida and Ardeshir Hakam and Hiroko Machida and Paulette Mhawech-Fauceglia and Yutaka Ueda and Kiyoshi Yoshino and Hiroshi Kajiwara and Kosei Hasegawa and Masanori Yasuda and Miyake, {Takahito M.} and Takuya Moriya and Yoshiaki Yuba and Terry Morgan and Tomoyuki Fukagawa and Tanja Pejovic and Tadayoshi Nagano and Takeshi Sasaki and Richmond, {Abby M.} and Post, {Miriam D.} and Shahzad, {Mian M.K.} and Im, {Dwight D.} and Hiroshi Yoshida and Kohei Omatsu and Ueland, {Frederick R.} and Kelley, {Joseph L.} and Karabakhtsian, {Rouzan G.} and Roman, {Lynda D.}",
year = "2018",
month = "9",
day = "1",
doi = "10.1016/j.suronc.2018.05.017",
language = "English (US)",
volume = "27",
pages = "433--440",
journal = "Surgical Oncology",
issn = "0960-7404",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Characterizing sarcoma dominance pattern in uterine carcinosarcoma

T2 - Homologous versus heterologous element

AU - Matsuo, Koji

AU - Takazawa, Yutaka

AU - Ross, Malcolm S.

AU - Elishaev, Esther

AU - Yunokawa, Mayu

AU - Sheridan, Todd B.

AU - Bush, Stephen H.

AU - Klobocista, Merieme M.

AU - Blake, Erin A.

AU - Takano, Tadao

AU - Baba, Tsukasa

AU - Satoh, Shinya

AU - Shida, Masako

AU - Ikeda, Yuji

AU - Adachi, Sosuke

AU - Yokoyama, Takuhei

AU - Takekuma, Munetaka

AU - Yanai, Shiori

AU - Takeuchi, Satoshi

AU - Nishimura, Masato

AU - Iwasaki, Keita

AU - Johnson, Marian S.

AU - Yoshida, Masayuki

AU - Hakam, Ardeshir

AU - Machida, Hiroko

AU - Mhawech-Fauceglia, Paulette

AU - Ueda, Yutaka

AU - Yoshino, Kiyoshi

AU - Kajiwara, Hiroshi

AU - Hasegawa, Kosei

AU - Yasuda, Masanori

AU - Miyake, Takahito M.

AU - Moriya, Takuya

AU - Yuba, Yoshiaki

AU - Morgan, Terry

AU - Fukagawa, Tomoyuki

AU - Pejovic, Tanja

AU - Nagano, Tadayoshi

AU - Sasaki, Takeshi

AU - Richmond, Abby M.

AU - Post, Miriam D.

AU - Shahzad, Mian M.K.

AU - Im, Dwight D.

AU - Yoshida, Hiroshi

AU - Omatsu, Kohei

AU - Ueland, Frederick R.

AU - Kelley, Joseph L.

AU - Karabakhtsian, Rouzan G.

AU - Roman, Lynda D.

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Objective: To examine significance of sarcoma dominance (SD) patterns in uterine carcinosarcoma (UCS). Methods: This is a secondary analysis of multicenter retrospective study examining women with stages I-IV UCS who underwent primary surgery. SD was defined as >50% of sarcoma component in uterine tumor. SD patterns were grouped as homologous sarcoma without SD (homo/non-dominance, n = 351), heterologous sarcoma without SD (hetero/non-dominance, n = 174), homologous sarcoma with SD (homo/dominance, n = 175), and heterologous sarcoma with SD (hetero/dominance, n = 189), and correlated to tumor characteristics and survival. Results: SD patterns were significantly associated with age, body habitus, carcinoma type, tumor size, depth of myometrial invasion, and nodal metastasis (all, P < 0.05). On univariate analysis, SD was associated with decreased progression-free survival (PFS) and cause-specific survival (CSS) in homologous cases (both, P < 0.05) but not in heterologous cases. On multivariate models, both homologous and heterologous SD patterns remained independent prognostic factors for decreased PFS (adjusted-hazard ratio [HR] ranges: homo/dominance 1.35–1.69, and hetero/dominance 1.47–1.64) and CSS (adjusted-HR ranges: 1.52–1.84 and 1.66–1.81, respectively) compared to homo/non-dominance (all, P < 0.05). Among stage I-III disease, when tumors had SD, adding radiotherapy to chemotherapy was significantly associated with improved PFS (adjusted-HR: homo/dominance 0.49, and hetero/dominance 0.45) and CSS (0.36 and 0.31, respectively) compared to chemotherapy alone (all, P < 0.05); contrary, this association was not observed with absence of SD (all, P > 0.05). Conclusion: In UCS, SD impacts survival in homologous but not in heterologous type. Regardless of sarcoma types, SD was associated with decreased survival in UCS; adding radiotherapy to chemotherapy may be an effective postoperative strategy.

AB - Objective: To examine significance of sarcoma dominance (SD) patterns in uterine carcinosarcoma (UCS). Methods: This is a secondary analysis of multicenter retrospective study examining women with stages I-IV UCS who underwent primary surgery. SD was defined as >50% of sarcoma component in uterine tumor. SD patterns were grouped as homologous sarcoma without SD (homo/non-dominance, n = 351), heterologous sarcoma without SD (hetero/non-dominance, n = 174), homologous sarcoma with SD (homo/dominance, n = 175), and heterologous sarcoma with SD (hetero/dominance, n = 189), and correlated to tumor characteristics and survival. Results: SD patterns were significantly associated with age, body habitus, carcinoma type, tumor size, depth of myometrial invasion, and nodal metastasis (all, P < 0.05). On univariate analysis, SD was associated with decreased progression-free survival (PFS) and cause-specific survival (CSS) in homologous cases (both, P < 0.05) but not in heterologous cases. On multivariate models, both homologous and heterologous SD patterns remained independent prognostic factors for decreased PFS (adjusted-hazard ratio [HR] ranges: homo/dominance 1.35–1.69, and hetero/dominance 1.47–1.64) and CSS (adjusted-HR ranges: 1.52–1.84 and 1.66–1.81, respectively) compared to homo/non-dominance (all, P < 0.05). Among stage I-III disease, when tumors had SD, adding radiotherapy to chemotherapy was significantly associated with improved PFS (adjusted-HR: homo/dominance 0.49, and hetero/dominance 0.45) and CSS (0.36 and 0.31, respectively) compared to chemotherapy alone (all, P < 0.05); contrary, this association was not observed with absence of SD (all, P > 0.05). Conclusion: In UCS, SD impacts survival in homologous but not in heterologous type. Regardless of sarcoma types, SD was associated with decreased survival in UCS; adding radiotherapy to chemotherapy may be an effective postoperative strategy.

KW - Heterologous

KW - Homologous

KW - Sarcoma dominance

KW - Survival

KW - Uterine carcinosarcoma

UR - http://www.scopus.com/inward/record.url?scp=85049321797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049321797&partnerID=8YFLogxK

U2 - 10.1016/j.suronc.2018.05.017

DO - 10.1016/j.suronc.2018.05.017

M3 - Article

VL - 27

SP - 433

EP - 440

JO - Surgical Oncology

JF - Surgical Oncology

SN - 0960-7404

IS - 3

ER -